Pathology Sciences Lab Manager
Currently Pathology Sciences Lab Manager at AstraZeneca since March 2016, based at the new Cambridge site and responsible for the EU Histology team in the Drug Safety and Metabolism organisation. Began histology career at GSK in 1992 and has since held numerous positions in the field in a number of big pharma and CRO organisations (Novartis, HLS, Propath). Main area of experience has been in developing new IHC assays to support investigative safety and supporting tissue biomarkers as well as the drug development of therapeutic antibodies by establishing robust assays for use in tissue cross reactivity studies. Current focus of team is developing more ISH based technologies and image analysis capabilities across the AZ Pathology department to increase depth of pathology data and contributions to modelling and simulation activities.